Bora Pharmaceuticals: Transforming Taiwan's Biotech Landscape

Published

By TaiwanPlus

How does the presence of Contract Development and Manufacturing Organizations (CDMOs) impact Taiwan's pharmaceutical sector? In this episode of TaiwanTalks, Bora Pharmaceuticals CEO Bobby Sheng shares his expertise of the worldwide pharmaceutical CDMO market. He illuminates the biotech landscape and crucial role Taiwan plays in this system. Our guests are: Bobby Sheng - Chair and CEO, Bora Pharmaceuticals